Docusign Inc. (NASDAQ:DOCU - Free Report) - Research analysts at Zacks Research dropped their Q2 2027 EPS estimates for shares of Docusign in a report issued on Thursday, June 26th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.24 for the quarter, down from their prior estimate of $0.28. The consensus estimate for Docusign's current full-year earnings is $1.17 per share.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.09. The firm had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%. Docusign's quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the business posted $0.82 EPS.
Other equities research analysts have also recently issued reports about the stock. Jefferies Financial Group lowered their price objective on shares of Docusign from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, March 31st. Hsbc Global Res raised shares of Docusign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. Bank of America lowered their price target on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. UBS Group cut their price objective on Docusign from $85.00 to $80.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Finally, Robert W. Baird reduced their target price on Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Twelve research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, Docusign currently has an average rating of "Hold" and an average price target of $89.77.
Get Our Latest Analysis on DOCU
Docusign Stock Up 1.2%
Shares of DOCU stock opened at $76.47 on Monday. The stock has a market cap of $15.45 billion, a P/E ratio of 14.46, a P/E/G ratio of 29.00 and a beta of 1.14. Docusign has a fifty-two week low of $48.80 and a fifty-two week high of $107.86. The business has a fifty day simple moving average of $82.17 and a 200-day simple moving average of $85.04.
Docusign announced that its board has initiated a stock repurchase program on Thursday, June 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to purchase up to 6.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its shares are undervalued.
Insiders Place Their Bets
In related news, insider Robert Chatwani sold 22,875 shares of the business's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the sale, the insider now directly owns 72,126 shares in the company, valued at approximately $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total transaction of $609,825.00. Following the transaction, the insider now directly owns 45,875 shares of the company's stock, valued at $3,730,096.25. This trade represents a 14.05% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 54,052 shares of company stock valued at $4,101,776 in the last quarter. 1.66% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Docusign
Hedge funds have recently made changes to their positions in the stock. Hemington Wealth Management raised its position in shares of Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after buying an additional 264 shares during the period. Banque Transatlantique SA acquired a new stake in Docusign during the first quarter worth about $26,000. Golden State Wealth Management LLC raised its holdings in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares during the period. Summit Securities Group LLC acquired a new position in shares of Docusign in the 1st quarter valued at about $34,000. Finally, Wood Tarver Financial Group LLC acquired a new position in shares of Docusign in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 77.64% of the company's stock.
About Docusign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.